PhagoMed advances to EIT Health Finals
Yesterday the biotech semi-finals of the EIT Health Catapult competition took place. Fourteen exceptional biotechs from all across Europe competed for a spot in the finals. PhagoMed was selected by a high-calibre jury as one of the seven winners of the semifinals and will advance to the EIT Health Catapult finals in early December.
In addition to being named a Finalist, PhagoMed has received a sponsor prize in the category of Market Access and will have the opportunity to closely work with the French organization LallianSe.
The finals will take place virtually as part of the EIT Health Summit 2020: For more information, please visit the EIT Health Summit website: https://www.summit.eithealth.eu/.